These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 8514867

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.
    Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ.
    Q J Med; 1990 Oct; 77(282):1019-38. PubMed ID: 2267280
    [Abstract] [Full Text] [Related]

  • 24. Antibody to threonyl-transfer RNA synthetase in myositis sera.
    Targoff IN, Arnett FC, Reichlin M.
    Arthritis Rheum; 1988 Apr; 31(4):515-24. PubMed ID: 3128989
    [Abstract] [Full Text] [Related]

  • 25. Myositis autoantibody reactivity and catalytic function of threonyl-tRNA synthetase.
    Dang CV, Tan EM, Traugh JA.
    FASEB J; 1988 May; 2(8):2376-9. PubMed ID: 2452112
    [Abstract] [Full Text] [Related]

  • 26. Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
    Hervier B, Devilliers H, Benveniste O.
    Ann Rheum Dis; 2013 Jul; 72(7):e18. PubMed ID: 23644669
    [No Abstract] [Full Text] [Related]

  • 27. Spectrum and clinical significance of autoantibodies against transfer RNA.
    Ohosone Y, Ishida M, Takahashi Y, Matsumura M, Hirakata M, Kawahara Y, Nishikawa T, Mimori T.
    Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095
    [Abstract] [Full Text] [Related]

  • 28. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Human anti-asparaginyl-tRNA synthetase autoantibodies (anti-KS) increase the affinity of the enzyme for its tRNA substrate.
    Beaulande M, Kron M, Hirakata M, Härtlein M.
    FEBS Lett; 2001 Apr 13; 494(3):170-4. PubMed ID: 11311235
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?
    Lega JC, Cottin V, Fabien N, Thivolet-Béjui F, Cordier JF.
    J Rheumatol; 2010 May 13; 37(5):1000-9. PubMed ID: 20231208
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time].
    Hengstman GJ, van Venrooij WJ, van den Hoogen FH, van Engelen BG.
    Ned Tijdschr Geneeskd; 2003 Aug 02; 147(31):1485-9. PubMed ID: 12924076
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.